Pathophysiological Mechanisms Implicated in Postpartum Depression
January 2019
in “
Frontiers in Neuroendocrinology
”
Studysummary This review summarizes proposed pathophysiological mechanisms of postpartum depression, highlighting neuroendocrine and neurobiological changes, but reports no new findings and calls for integrated understanding of the disorder.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The 2018 review discussed various pathophysiological mechanisms contributing to postpartum depression, including neuroendocrine changes, neuroinflammation, neurotransmitter alterations, circuit dysfunction, and genetic and epigenetic involvement. Risk factors such as stress and adverse life events were highlighted. The document also discussed potential biomarkers for postpartum depression, including the neuroactive steroid allopregnanolone, higher levels of ß-endorphin, reduced platelet serotonin levels, increased monoamine oxidase-A density, low omega-3 levels, and lower vitamin D levels. Genetic influences were also considered, focusing on genes like the serotonin transporter, tryptophan hydroxylase-2 (TPH2), Catechol-O-methyl transferase (COMT), Monoamine Oxidase (MAO), and Brain Derived Neurotrophic Factor (BDNF). The review concluded that these mechanisms are interconnected and may collectively contribute to postpartum depression.
